Siirry päänavigointiin
Siirry hakuun
Siirry pääsisältöön
Tampereen yliopiston tutkimusportaali Etusivu
Tuki ja usein esitetyt kysymykset
English
Suomi
Etusivu
Profiilit
Tutkimusyksiköt
Tutkimustuotos
Aktiviteetit
Tietoaineistot
Tutkimusinfrastruktuurit
Lehtileikkeet
Palkinnot
Haku asiantuntemuksen, nimen tai kytköksen perusteella
Gut Connection in IgA Nephropathy
Jussi Pohjonen
Sisätautialat, keuhkosairaudet & akuuttihoito, iho ja allergiasairaudet, työterveys- ja perusterveydenhuolto, farmakologia
SIST, Sisätaudit
Tutkimustuotos
:
Väitöskirja
›
Collection of Articles
Yleiskatsaus
Sormenjälki
Sormenjälki
Sukella tutkimusaiheisiin 'Gut Connection in IgA Nephropathy'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.
Järjestys:
Painoarvo
Aakkosjärjestyksessä
Medicine and Dentistry
Gut
100%
Immunoglobulin A Nephropathy
100%
Inflammatory Bowel Disease
46%
Prevalence
42%
Gastrointestinal Distress
39%
Biological Marker
21%
Coeliac Disease
17%
Renal Biopsy
10%
Intestine Injury
10%
Rating Scale
10%
Disease
7%
Volunteer
7%
Quality of Life
7%
Intestine
7%
Autoimmunity
7%
Crohn's Disease
7%
Patient Experience
7%
Nephropathy
7%
End Stage Renal Disease
7%
Interstitial Nephritis
7%
Intestinal Permeability
7%
Stomach Acid
7%
Kidney Function
3%
Population
3%
Infection
3%
Corticosteroid Therapy
3%
Autoantibodies
3%
Ulcerative Colitis
3%
Enteropathy
3%
Renal Failure
3%
Faecal Calprotectin
3%
Biopsy Technique
3%
Microhematuria
3%
Glomerulonephritis
3%
Protein Glutamine Gamma Glutamyltransferase 2
3%
Cell Damage
3%
Lipopolysaccharide Binding Protein
3%
Fatty Acid Binding Protein 2
3%
Keyphrases
IgA Nephropathy (IgAN)
100%
Inflammatory Bowel Disease
46%
Serum Levels
28%
Gastrointestinal Diseases
25%
Healthy People
17%
Tampere
10%
University Hospital
10%
Intestine
10%
Celiac Disease
10%
Kidney Biopsy
10%
Intestinal Injury
10%
Gastrointestinal Symptom Rating Scale
10%
Indirect Biomarker
10%
Kidney
7%
Healthy Individuals
7%
Health-related Quality of Life
7%
Patient Experience
7%
Kidney Disease
7%
Dyspepsia
7%
Tubulointerstitial Nephritis
7%
End-stage Kidney Disease
7%
Coeliac Autoimmunity
7%
Healthy Controls
3%
21st Century
3%
Clinical Signs
3%
Clinical Indications
3%
Histology
3%
Catchment Area
3%
Cell Damage
3%
Non-associated
3%
Cluster of Differentiation
3%
Female Patients
3%
Clinical Presentation
3%
Intestinal Permeability
3%
Enterocyte
3%
Crohn's Disease
3%
Patient-controlled
3%
Autoantibody Detection
3%
Population Prevalence
3%
Gastrointestinal Problems
3%
Fecal Calprotectin
3%
Celiac Disease Autoimmunity
3%
Increased Intestinal Permeability
3%
Dialysis Patients
3%
Corticosteroid Therapy
3%
Refractory Celiac Disease
3%
Transglutaminase 2
3%
Gross Hematuria
3%
Kidney Failure
3%
Psychological General Well-Being
3%
I-FABP
3%
Symptom Level
3%
Lipopolysaccharide-binding Protein
3%
Crohn's Colitis
3%
Preserved Renal Function
3%
Mucosal Infection
3%
Gut-kidney Axis
3%
Targeting Antibodies
3%
Volunteer Patients
3%
Primary Glomerulonephritis
3%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin A Nephropathy
100%
Inflammatory Bowel Disease
46%
Prevalence
42%
Gastrointestinal Symptom
39%
Normal Human
21%
Biological Marker
21%
Coeliac Disease
17%
Intestine Injury
10%
Disease
7%
Crohn's Disease
7%
Intestinal Permeability
7%
End Stage Renal Disease
7%
Interstitial Nephritis
7%
Kidney Disease
7%
Stomach Acid
7%
Infection
3%
Kidney Failure
3%
Ulcerative Colitis
3%
Calgranulin
3%
Enteropathy
3%
Autoantibodies
3%
Protein Glutamine Gamma Glutamyltransferase 2
3%
Glomerulonephritis
3%
Fatty Acid Binding Protein 2
3%
Lipopolysaccharide Binding Protein
3%
Hematuria
3%
Immunology and Microbiology
Stomach Acid
7%